Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Cognitive Impairment in Pediatric CNS Tumors
NCT04217694Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of memantine in radiation-induced cognitive impairment (RICI), sponsored by Mayo Clinic. Primary endpoint: Percentage of patients who attempt to take appropriate dose of memantine. Started Feb 2020; status: completed.
02
Drugs
memantine
03
Conditions
radiation-induced cognitive impairment (RICI)
Beyond the preview
Go deeper on NCT04217694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04217694.